Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Adjuvant Renal Cell Carcinoma
NCT00375674Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2007
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Aug 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00375674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375674.